Pfizer Booster Shots
- All
- News
- Videos
-
US Is Considering Second Covid Booster For 65+
Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
South Africa To Roll Out Covid Booster Shots Next Month
South Africa will next month start giving Pfizer booster shots against coronavirus, a health official said Friday, a day after the country reported a near-record high in daily cases of the disease.
-
South Africa Approves Coronavirus Vaccine Boosters For Adults
South Africa on Wednesday approved Pfizer's coronavirus booster shots for over-18s, as the Omicron variant dominates rising new infections.
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Pfizer Seeks US Approval For Covid Boosters For Ages 16-17
Pfizer announced Tuesday it was seeking US authorization for Covid booster shots among adolescents aged 16 and 17, as concerns grow about the impact of the new Omicron variant.
-
US Clears Covid Boosters For All Adults
The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday, as the world's hardest-hit country enters a new winter wave of the pandemic.
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
-
Third Dose Of Pfizer's COVID-19 Vaccine 95.6% Effective: Study
A third dose of the vaccine against COVID-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Covid Protection Wanes Months After Second Shot, Booster Needed: Study
Immunity provided by the Covid-19 vaccine from partners Pfizer Inc. and BioNTech SE weakens significantly within months, with men having less protection than women, according to research that supports the use of booster doses.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
-
US Is Considering Second Covid Booster For 65+
Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
-
US Authorizes Pfizer COVID-19 Booster Shot For Children As Young As 12
US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.
-
South Africa To Roll Out Covid Booster Shots Next Month
South Africa will next month start giving Pfizer booster shots against coronavirus, a health official said Friday, a day after the country reported a near-record high in daily cases of the disease.
-
South Africa Approves Coronavirus Vaccine Boosters For Adults
South Africa on Wednesday approved Pfizer's coronavirus booster shots for over-18s, as the Omicron variant dominates rising new infections.
-
For Omicron, Third Dose Of Covid Shot May Be Needed: Pfizer
Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Pfizer Seeks US Approval For Covid Boosters For Ages 16-17
Pfizer announced Tuesday it was seeking US authorization for Covid booster shots among adolescents aged 16 and 17, as concerns grow about the impact of the new Omicron variant.
-
US Clears Covid Boosters For All Adults
The United States authorized the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday, as the world's hardest-hit country enters a new winter wave of the pandemic.
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
-
Third Dose Of Pfizer's COVID-19 Vaccine 95.6% Effective: Study
A third dose of the vaccine against COVID-19 developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
Moderna Covid Booster Shot Backed By US Expert Panel For At-Risk Adults
An expert committee on Thursday recommended a booster dose of Moderna's anti-Covid vaccine in the United States for certain at-risk groups, a month after making a similar decision for the Pfizer shot.
-
Covid Protection Wanes Months After Second Shot, Booster Needed: Study
Immunity provided by the Covid-19 vaccine from partners Pfizer Inc. and BioNTech SE weakens significantly within months, with men having less protection than women, according to research that supports the use of booster doses.
-
US Committee Challenges Pfizer's Covid Booster Authorisation For High-Risk Adults
A committee of US health experts on Thursday declined to approve Pfizer booster shots for individuals at high risk of Covid exposure due to their jobs, despite authorization from a different agency just the night before.
